Respondents (n) | Respondents following guideline ± 20% | ||||||
Agent | Total | Yes | No | Total | Yes | No | Guideline-recommended dosage* |
Boy | |||||||
99mTc-MDP | 50 | 26 | 18 | 66.0% | 88.5% | 38.9% | 185.0 (5) |
99mTc-MAG3 | 42 | 27 | 12 | 45.2% | 55.6% | 25.0% | 111.0 (3) |
99mTc-DMSA | 37 | 23 | 12 | 54.1% | 69.6% | 25.0% | 37.0 (1) |
99mTc-HIDAs | 27 | 15 | 10 | 48.2% | 73.3% | 10.0% | 37.0 (1) |
18F-FDG | 20 | 14 | 5 | 70.0% | 78.6% | 60.0% | 74.0–103.6 (2.0–2.8) |
Girl | |||||||
99mTc-MDP | 50 | 26 | 18 | 50.0% | 84.6% | 44.4% | 277.5 (7.5) |
99mTc-MAG3 | 43 | 27 | 12 | 45.2% | 55.6% | 25.0% | 166.5 (4.5) |
99mTc-DMSA | 37 | 23 | 12 | 51.4% | 65.2% | 33.3% | 55.5 (1.5) |
99mTc-HIDAs | 27 | 15 | 10 | 40.7% | 73.3% | 10.0% | 55.5 (1.5) |
18F-FDG | 20 | 14 | 5 | 70.0% | 85.7% | 60.0% | 111.0–155.4 (3.0–4.2) |
↵* Units of measurement are megabecquerels (MBq) followed by millicuries (mCi) in parentheses.
The hypothetical patients are a 5-y-old, 20-kg, 110-cm boy and a 10-y-old, 30-kg, 140-cm girl.